Featured
Learn about the most recent information released at the annual San Antonio Breast Cancer Symposium regarding metastatic breast cancer research with Dr. Peter Schmid, Professor of Cancer Medicine at Barts Cancer Institute in London, England. Dr. Schmid will provide a comprehensive update and answer your questions about these new developments.
On 10/12/21 Lianne Kraemer, an MBC patient advocate living with brain mets , and SHARE hosted two brilliant young clinicians from Moffitt in a discussion on management of breast cancer brain metastases. Today we are bringing you this webinar with our additional commentary. We will let you in on a little secret. This episode is a glimpse into how we envision the next season’s Road to a Cure. It will include more content with an educational angle for the newly diagnosed or those who are ready to take a deeper dive with us into the basics. We call it MBC101.
It is fitting that our 7th and last stop before the SABCS is back to NYC. Co-hosts Lisa Laudico and Ellen Landsberger talk with Dr Sarat Chandarlapaty, a leading Physician Scientist at MSKCC. As both a physician treating patients and a scientist in the lab, Dr. Chandarlapaty gives us an understanding of translational medicine, transferring what he learns from his patients back into the lab to answer questions that advance the treatment of metastatic breast cancer.
The Season of Giving is upon us. Purely by chance, we may be starting a new tradition here on the Trailblazer series - guests bearing gifts. This gift will be symbolically unwrapped during this interview with this month’s Trailblazer - national nonprofit United for HER and Susan Weldon, Founder and CEO.
The Our MBC Life podcast hosts a panel to discuss what it’s really like to be diagnosed stage 4 from the beginning or de novo MBC. Those of us diagnosed de novo don’t get an introduction to breast cancer at earlier stages and that presents some unique issues.
This is the sixth stop in our series Road to a Cure. From the start our goal for this series was not only to educate and give hope to every listener but also to ensure that each of these special interviews feels like an intimate conversation with our smartest friend who also happens to be an oncologist researcher. This episode will not disappoint., Co-hosts Victoria Goldberg and Lisa Laudico, sit down with the Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon, Portugal, Dr. Fatima Cardoso.
How famous is Dr Hope Rugo? She belongs to a tiny elite group of oncologists who have their own Wikipedia page. Dr. Dennis Slamon is quite possibly the only other member. Enough said. No surprise that we can’t wait to hear what she has to say about a new class of drugs, known as ADCs and specifically, the first ADC for mTNBC that already has a nickname – Sassy (sacituzumab govitecan). Do you know what a SARM is? It is a special class of drugs for those who are Androgen Receptor (AR) positive. Listen and find out.
Our episode this week will focus on body image and diet culture, both within society and the breast cancer community, and how treatment can affect our feelings about our bodies. Co-host Natalia Green moderates a panel of women currently living with MBC who discuss and share their experiences.
This week we are visiting Dr Stephanie Goff at the NIH in Bethesda, Maryland. Dr Goff is a surgical oncologist and a senior member of a research team led by Dr. Steven A. Rosenberg, a man widely regarded as the father of immunotherapy. A friend, who knows a thing or two about this place. is joining us on this trip. Her name is Judy Perkins, and she is the first MBC patient who has been cured by a revolutionary immunotherapy treatment, known as adoptive cell therapy, that was administered by Dr Goff and her colleagues at the NCI.
The Road to a Cure series heads to Boston to have Senior Producer and Co-host, Victoria Goldberg and co-host Dr. Paula Jayne speak with Dr. Nancy Lin and Dr. Heather Parsons about the possibilities and the current barriers to considering a cure for HER2+ MBC. Dr. Parsons and Dr. Lin are medical oncologists and professors at Harvard Medical School. Dr. Lin is also the Director of the Metastatic Breast Cancer Program and the Associate Chief of the Division of Breast Oncology at Dana Farber Cancer Institute. While an amazing gift, long-term survival among some HER2+ patients can also sometimes bring special challenges. Given the higher prevalence of brain metastases among HER2+ patients, Drs. Lin and Parsons also discuss current research on brain mets, along with areas of promising overall MBC research for each subtype.
Join us for our annual We Remember episode where we have invited our listeners to share the names and stories of the people they have loved and who have died from MBC over these past 12 months. Together we share the grief and loss of everyone who has died from MBC. Thanks for listening.
The Road to a Cure series gets on the redeye to LA to have Senior Producer and Co-host, Victoria Goldberg and co-host Kate Pfitzer speak with Dr. Sara Hurvitz. She talks about her perspective on where we are as we work for a cure, the HER2+ studies she is excited about, and other research that is intriguing as it relates to all subtypes
Our special series, Road to a Cure, makes its first stop at Memorial Sloan Kettering Cancer Center in New York, with an interview with Dr. Larry Norton. He is Senior Vice President in the Office of the President, and Deputy Director for Clinical and Translational Science in the Memorial Sloan Kettering Cancer Center. Dr. Norton’s also the Medical Director of the Evelyn H. Lauder Breast Center at MSK and a founder of the Breast Cancer Research Foundation. Senior Producer & Host Lisa Laudico and co-host Dr. Ellen Landsberger speak with Dr. Norton on what he sees happening with Metastatic Breast Cancer research today. They ask him about what lines of research are most exciting to him and also all about how he cares for his own mental health
The podcast team has embarked upon something quite ambitious. The members of the team have traveled virtually to speak with the leading clinicians and researchers in the field of breast cancer, specifically on the topic of where we are in terms of a cure for metastatic breast cancer. It is impossible to cover it in a neat single episode, so, instead, we created a very special series of episodes that we call “Road to A Cure.” In this premiere episode the members of the creative team share with the audience what it means to live with an incurable disease. We talk about a possibility of a cure, address the real fear of hoping, and tackle these and many other important issues.
Grab those negative covid tests and passports because we travel around the world in this episode! Oh yeah, get your proof of vaccination and N95s too since this thing ain’t over yet sadly. We wanted to learn how others living with and advocating for MBC deal with it all in other places. So we travel virtually to Canada, Japan, Kuwait, Egypt, Australia, Portugal, Kenya, Nigeria, and the UK. Co-hosts Natalia Green, Sheila McGlown, Lisa Laudico, and Anne Woodward find out what it’s like to get a second opinion in Europe & Canada, or why MBC is called Advanced Breast Cancer in some places, or how getting drugs in some countries is like applying for a car loan, or the debilitating stigma of cancer and so much more.
We begin the Season 3 Trailblazers with a twist. We’re taking Trailblazer on the Road! Our first stop will be the wonderfully, philanthropic city of Charlotte, NC. Join us as we speak with representatives of two truly grassroots organizations, dedicated to supporting the Charlotte breast cancer community in two very different ways. Interestingly enough, both organizations were started by women living with Metastatic Breast Cancer.
We believe that Black History Month should always be celebrated but let's agree that it should not be just for one month but every month and every day.